Memantine Accord

Memantine, the active ingredient in Memantine Accord, is a NMDA receptor antagonist presented as a tablet for oral use. It is indicated for the treatment of Alzheimer’s disease in adult patients, helping to manage cognitive symptoms associated with the condition.

GNH USA supplies Memantine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for healthcare providers across multiple regions. Its global distribution network ensures timely delivery and regulatory compliance for each order.

Memantine is an NMDA receptor antagonist used in the management of Alzheimer’s disease.

- Mild Alzheimer’s disease: helps maintain cognitive function and daily living activities. - Moderate Alzheimer’s disease: may improve memory and reasoning abilities. - Severe Alzheimer’s disease: provides modest benefit in cognition and functional status.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Headache: mild to moderate intensity. - Constipation: reduced bowel movements. - Confusion: occasional disorientation. - Fatigue: feeling of tiredness. - Hypertension: elevated blood pressure readings.

Serious or Rare Side Effects: - Seizures: convulsive episodes requiring immediate medical attention. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Hallucinations: visual or auditory disturbances. - Cardiac arrhythmia: irregular heart rhythm that may be life‑threatening.

Memantine should be used with clinical oversight and consideration of patient‑specific factors.

- Renal impairment: assess kidney function and adjust dosing if necessary. - Hepatic impairment: monitor liver enzymes during therapy. - History of seizures: use with caution and observe for increased seizure activity. - Concomitant NMDA agonists: avoid co‑administration due to opposing mechanisms. - Pregnancy and lactation: safety not established; prescribe only if benefits outweigh risks. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Memantine may interact with several medicines; monitoring is recommended.

Major Interactions (Avoid): - Amantadine: combined use can increase central nervous system adverse effects. - Ketamine: additive NMDA antagonism may heighten toxicity.

Moderate Interactions (Monitor Closely): - Acetylcholinesterase inhibitors (e.g., donepezil): may reduce overall therapeutic benefit. - Diuretics (e.g., furosemide): can raise plasma memantine concentrations. - CNS depressants (e.g., benzodiazepines): may enhance sedation and dizziness.